Dr. Gyorgy Abel is the Director of Clinical Chemistry, Molecular Diagnostics, and Immunology at the
Lahey Hospital & Medical Center in Burlington, Massachusetts. He also serves as Clinical Instructor in
Pathology at Harvard Medical School. Dr. Abel is board certified in Clinical Pathology (American Board of
Pathology) and Molecular Diagnostics (DABCC), and is a Fellow of the College of American Pathologists
(CAP), the National Academy of Clinical Biochemistry (NACB), and the Royal Society of Medicine (UK).
He has over twenty-five years of experience in molecular biology and diagnostics.
His clinical and research interests include the molecular pathology of hepatitis C infection, minimal residual disease detection in cancer, and personalized medicine. Dr. Abel previously served as Vice President of the American Board of Clinical Chemistry. Currently, he is a member of the Genomic Analysis Resource Guide Work Group of the College of American Pathologists (CAP), the Clinical and Translational Research Subcommittee of the Federation of American Societies for Experimental Biology (FASEB), the Clinical Immunology Committee of the American Association of Immunologists (AAI), and the Clinical Advisory Committee of the Reference Material Institute for Clinical Chemistry Standards (ReCCS) in Japan.